Syndrome des antiphospholipides

Syndrome des antiphospholipides

  
Saccone G et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol. 2017 Jan 30Lire le résumé
Cochery-Nouvellon É et al. Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes. The NOH-ANGIO observational cohort study. Haematologica. 2017 Jan 25Lire le résumé
Abrahams VM et al. The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome. J Hum Genet. 2017 Apr 20Lire le résumé
Mimi Kim et al. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid syndrome Ann Rheum Dis published on January 25, 2018Lire le résumé
Rashidi A, Fisher SI. Clinical Images: Lupus erythematosus cell. Arthritis & Rheumatology. 2018 May
14


Nakamura H, Fujieda Y, Yasuda S, Nakai M, Atsumi T. Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus. Ann
Intern Med. 2018 May 1;


Sciascia Sciascia SS, Rubini E, Radin M, Cecchi I, Rossi D, Roccatello D. Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab. Annals of the Rheumatic Diseases. 2018 May 18;
annrheumdis-2018-213496.
Lire le résumé
Pengo V, Denas G, Zoppellaro G, Padayattil Jose S, Hoxha A, Ruffatti A, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood. 2018 Jul 12;blood-2018-04-848333.Lire le résumé
Sanchez A, Montaudie H, Bory P, Belgodere X, Passeron T, Lacour JP, et al. Antiphospholipid Syndrome Following Pembrolizumab Treatment of Stage IIIB Unresectable Melanoma. JAMA Dermatology [Internet]. 2018 Sep 19 [cited 2018 Oct 23]; Lire le résumé
Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, et al. The Epidemiology of Antiphospholipid Syndrome. A Population‐Based Study. Arthritis Rheumatol [Internet]. 8 avr 2019 [cité 23
avr 2019]; Disponible sur: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40901
Lire le résumé
Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, et al. The Epidemiology of Antiphospholipid Syndrome. A Population‐Based Study. Arthritis Rheumatol [Internet]. 8 avr 2019 [cité 23
avr 2019]; Disponible sur: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40901
Lire le résumé
Gris J-C, Mousty È, Bouvier S, Ripart S, Cochery-Nouvellon É, Fabbro-Peray P, et al. Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome within the the NOH-APS cohort., Haematologica. 17 mai 2019;haematol.2018.213991Lire le résumé
Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, et al. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. Autoimmun Rev. avr 2019;18(4):406‑14Lire le résumé
Jesús G, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, et al. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome ( APS ) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study. BJOG Int J Obstet Gynaecol [Internet]. 24 oct 2018 [cité 14 mai 2019]; Disponible sur: https://onlinelibrary.wiley.com/doi/abs/10.1111/1471-0528.15469Lire le résumé
Yelnik CM, Lambert M, Drumez E, Le Guern V, Bacri J-L, Guerra MM, et al. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome. Lupus. sept 2018;27(10):1679 86Lire le résumé
Ordi-Ros J, Sáez-Comet L, Pérez-Conesa M, Vidal X, Riera-Mestre A, Castro-Salomó A, et al. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial. Ann Intern Med [Internet]. 15 oct 2019 [cité 23 oct 2019];
Lire le résumé
Chatzidionysiou K, Samoli E, Sfikakis PP, Tektonidou MG. Effect of belimumab treatment on antiphospholipid antibodies levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus. Ann Rheum Dis. 11 nov 2019;annrheumdis-2019-216367
Lire le résumé
Lockshin MD, Guerra M, Salmon JE. Elective termination of pregnancy in autoimmune rheumatic diseases. Arthritis Rheumatol [Internet]. 12 mars 2020 [cité 26 mars 2020]; Lire le résumé
You Y, Shi C, Zhou Z, Wang F, Sun Y, Teng J, et al. Rituximab in thrombotic primary antiphospholipid syndrome: a pilot study from a single centre in China. Ann Rheum Dis. 15 janv 2021;annrheumdis-2020-219303. Lire le résumé
Ruffatti A, Tonello M, Macor P, Calligaro A, Del Ross T, Favaro M, et al. Markers of complement activation in plasma during quiescent phases in catastrophic antiphospholipid syndrome patients. Blood [Internet]. 1 mars 2021 [cité 23 mars 2021];
Lire le résumé